As Wednesday’s trading session approaches, markets are abuzz with key developments across sectors. Oracle’s anticipated earnings report, a surprising rally in pharmaceutical stocks championed by Jim Cramer, and Target’s continued recovery are drawing investor focus. Meanwhile, the iShares MSCI Italy ETF is hitting new highs, and Trulieve is making history as the first U.S. cannabis company to list on the NYSE, reflecting significant federal policy shifts.
As Wall Street gears up for the next trading session, several key players and sectors are poised to capture investor attention. From tech giants reporting earnings to surprising sector rallies and emerging market plays, Wednesday promises a dynamic market landscape.
Oracle Takes Center Stage Ahead of Earnings
Tech behemoth Oracle (ORCL) is set to unveil its earnings report after the closing bell on Wednesday. The company has seen impressive momentum, with its stock surging nearly 36% over the past three months. CNBC options reporter Oliver Renick highlighted on Tuesday that the implied move for Oracle's stock post-earnings is a significant 12%, based on historical reactions. Interestingly, call buying outpaced puts by a 2-to-1 margin on Tuesday, suggesting bullish sentiment among some investors. CNBC’s Seema Mody will provide immediate analysis as the numbers cross the wire.
Pharmaceuticals: A Healthy Outlook?
The pharmaceutical sector is catching the eye of seasoned investors. Jim Cramer, host of "Mad Money," expressed his positive outlook on drug stocks Tuesday night, stating, "I like the drug stocks here." The S&P Health Care index climbed 1.3% on Tuesday, although it remains 3.5% below its February peak. More broadly, the S&P Pharma, Biotech, and Life Sciences Industry index has delivered an 8.6% gain in the last month. Cramer himself recently added Johnson & Johnson (JNJ) to his charitable trust, a move that has already yielded a 6% return since his June 1 purchase. Despite being 6% off its March 2 high, JNJ shares are up approximately 53% over the past year.
Target's Trajectory
Retail giant Target (TGT) continues its comeback story. CNBC Fast Money Trader Guy Adami noted on Tuesday night that Target’s shares have skyrocketed 52% from their November lows. The stock saw a 2% increase on Tuesday, although it's still trading 5% down from its April 21 high.
Italy's Market Heats Up
Overseas, Italy's market performance is generating buzz. CNBC's data guru Gina Francolla and "Morning Call" anchor Morgan Brennan extensively covered the nation's market strength on Tuesday. The iShares MSCI Italy ETF (EWI), which tracks leading Italian companies such as Ferrari, Leonardo, and various Italian banks, reached a new high during Tuesday’s session. While EWI surged 2.5% at one point, it ultimately closed up 1.5% for the day and boasts an impressive 11% gain over the last three months. Brennan is expected to delve deeper into this ETF on Wednesday's "Morning Call."
Trulieve Makes NYSE History Amid Cannabis Reforms
In a landmark development for the cannabis industry, Trulieve (TRLV) is set to become the first U.S. cannabis company to list on the New York Stock Exchange. This milestone follows recent federal changes concerning cannabis, which could unlock substantial investor capital for the sector. CNBC's Brandon Gomez, who closely follows the cannabis market, will report on this event. Trulieve’s stock experienced a volatile Tuesday, hitting a new high in the morning before seeing an 11% decline. Despite the intraday fluctuations, shares remain up 24% so far in June, underscoring the dynamic nature of this emerging market. The new ticker symbol will be TRLV.
